CN101843773B - Chinese medicament for treating liver cirrhosis - Google Patents
Chinese medicament for treating liver cirrhosis Download PDFInfo
- Publication number
- CN101843773B CN101843773B CN2009102361821A CN200910236182A CN101843773B CN 101843773 B CN101843773 B CN 101843773B CN 2009102361821 A CN2009102361821 A CN 2009102361821A CN 200910236182 A CN200910236182 A CN 200910236182A CN 101843773 B CN101843773 B CN 101843773B
- Authority
- CN
- China
- Prior art keywords
- chinese
- chinese medicine
- liver cirrhosis
- radix
- parts
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 28
- 206010019641 Hepatic cirrhosis Diseases 0.000 title claims abstract description 14
- 201000004044 liver cirrhosis Diseases 0.000 title claims abstract description 14
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 229940023488 Pill Drugs 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004369 Blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004185 Liver Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 208000005407 Digestive System Disease Diseases 0.000 abstract description 2
- 240000004678 Panax pseudoginseng Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 240000002012 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 230000035508 accumulation Effects 0.000 abstract 1
- 230000003213 activating Effects 0.000 abstract 1
- 201000010099 diseases Diseases 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 208000007502 Anemia Diseases 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N Kairine Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000003187 abdominal Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001737 promoting Effects 0.000 description 2
- 206010008909 Chronic hepatitis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 1
- 206010018987 Haemorrhages Diseases 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 208000007386 Hepatic Encephalopathy Diseases 0.000 description 1
- 206010019692 Hepatic necrosis Diseases 0.000 description 1
- 208000006454 Hepatitis Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 210000000088 Lip Anatomy 0.000 description 1
- 206010062080 Pigmentation diseases Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000005516 engineering processes Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000010419 fine particles Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002440 hepatic Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 201000002367 primary immunodeficiency diseases Diseases 0.000 description 1
- 239000011901 water Substances 0.000 description 1
Abstract
The invention relates to a Chinese medicament for treating liver cirrhosis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: fresh rehmannia root, Chinese wolfberry, lucid ganoderma, mix-fried turtle shell, radix pseudo-ginseng, Chinese angelica, cortex moutan and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, fostering yin and nourishing liver, and dissolving stasis and dispersing accumulations, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The Chinese medicine that is used for the treatment of liver cirrhosis at present, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of liver cirrhosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of liver cirrhosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Rehmanniae 4-30 part Fructus Lycii 4-30 part Ganoderma 2-15 part
Carapax Trionycis (processed) 4-30 part Radix Notoginseng 3-20 part Radix Angelicae Sinensis 4-30 part
Cortex Moutan 3-20 part
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Medical practice proves, liver cirrhosis patient is many because of the chronic hepatitis protracted course of disease, shows effect repeatedly and causes widely hepatic necrosis, large tracts of land hepatic fibrosis and cause that wherein hypoimmunity is crucial one-tenth cause of disease element.So the body resistance strengthening and constitution consolidating, enhancing human body immunity power should be the key link of treatment liver cirrhosis.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood are intended to enhancing human body immunity power in the side; Radix Rehmanniae, Fructus Lycii, the nourishing the liver of Carapax Trionycis (processed) nourishing YIN, the nourishing kidney of enriching blood; Cortex Moutan, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the merit of blood circulation promoting and blood stasis dispelling, nourishing YIN nourishing the liver, blood stasis dispelling removing food stagnancy, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Rehmanniae 50 gram Fructus Lyciis 50 kairine sesames 30 grams
Carapax Trionycis (processed) 50 gram Radix Notoginseng 40 gram Radix Angelicae Sinensis 50 grams
Cortex Moutan 40 grams
Weight in accordance with regulations, with conventional water extraction process Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted, make extractum fine powder 72 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Rehmanniae 180 gram Fructus Lyciis 180 kairine sesames 90 grams
Carapax Trionycis (processed) 200 gram Radix Notoginseng 120 gram Radix Angelicae Sinensis 120 grams
Cortex Moutan 120 grams
By above-mentioned same method, make 1607 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Rehmanniae 250 gram Fructus Lyciis 300 kairine sesames 130 grams
Carapax Trionycis (processed) 300 gram Radix Notoginseng 180 gram Radix Angelicae Sinensis 250 grams
Cortex Moutan 180 grams
By above-mentioned same method, make 2478 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
2 parts of 4 portions of Ganodermas of 5 portions of Fructus Lyciis of Radix Rehmanniae
5 parts of 3 parts of Radix Angelicae Sinensis of 5 portions of Radix Notoginseng of Carapax Trionycis (processed)
3 parts of Cortex Moutans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 20 portions of Ganodermas of 20 portions of Fructus Lyciis of Radix Rehmanniae
20 parts of 15 parts of Radix Angelicae Sinensis of 25 portions of Radix Notoginseng of Carapax Trionycis (processed)
15 parts of Cortex Moutans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 14 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially; Jaundice, anemia or bleeding tendency is arranged; Liver palm, spider angioma, cutaneous pigmentation and edema etc. appear.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 6 examples, women's 8 examples do not have other serious disease, and the age is 51 years old-76 years old, 66.2 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears; Hepatic fibrosis inspection index is obviously alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 6 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.14 philtrums of clinical experiment, produce effects 7 people, effective 6 people, invalid 1 people, total effective rate 92.8%.
Claims (1)
1. a Chinese medicine for the treatment of liver cirrhosis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Rehmanniae 4---15 parts of 30 portions of Fructus Lyciis 4---30 portions of Ganodermas 2---
Carapax Trionycis (processed) 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---
Cortex Moutan 3---20 parts
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Rehmanniae, Fructus Lycii, Carapax Trionycis (processed), Radix Angelicae Sinensis, Cortex Moutan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102361821A CN101843773B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating liver cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102361821A CN101843773B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating liver cirrhosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843773A CN101843773A (en) | 2010-09-29 |
| CN101843773B true CN101843773B (en) | 2011-09-28 |
Family
ID=42768711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102361821A CN101843773B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating liver cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843773B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953893A (en) * | 2010-10-14 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
| CN101972307A (en) * | 2010-10-21 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
| CN101966306A (en) * | 2010-10-27 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
| CN101966230A (en) * | 2010-11-04 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
| CN101991652A (en) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
| CN102138983A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating hepatocirrhosis |
| CN102091130A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
| CN102114080A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
| CN102172369A (en) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating hepatocirrhosis |
| CN102048831A (en) * | 2010-12-24 | 2011-05-11 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating cirrhosis |
-
2009
- 2009-10-22 CN CN2009102361821A patent/CN101843773B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843773A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN101961464B (en) | Chinese medicinal composition for treating jaundice and preparation method thereof | |
| CN100460008C (en) | Chinese medicine composition for treating cancer | |
| CN102670961B (en) | Traditional Chinese medicine for treating middle and old aged habitual constipation | |
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN103316205B (en) | Traditional Chinese medicine for treating iron-deficiency anemia and preparation method thereof | |
| CN104491801A (en) | Traditional Chinese medicine preparation for treating acute or chronic gastritis and preparation method thereof | |
| CN100478020C (en) | Stomatocase treating medicine | |
| CN103705782A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN101972386A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN101843773B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101537146B (en) | Chinese medicine for treating carcinoma of colon | |
| CN100462101C (en) | Medicament for treating aplastic anemia | |
| CN104491672A (en) | Traditional Chinese medicine preparation for treating chronic tracheitis and preparation method thereof | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN103920034A (en) | Traditional Chinese medicine composition for alleviating side effects of chemotherapy of cancer patient and preparation method traditional Chinese medicine composition | |
| CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN101530515B (en) | Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate | |
| CN102091225A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102068594A (en) | Chinese medicament for treating chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU XINZHUANG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150805 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150805 Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee after: Liu Xinzhuang Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |